Dr Adam Hartley MBBS PhD BSc(Hons) DIC PGCert FESC FRCP is a Consultant Cardiologist specialising in coronary and structural intervention at Imperial College Healthcare NHS Trust and an Honorary Clinical Senior Lecturer in Cardiovascular Sciences at the National Heart and Lung Institute (NHLI), Imperial College London.

He completed his undergraduate training at Guy's, King's and St Thomas' Medical School in 2013, achieving all Distinctions. This included an intercalated BSc in Pharmacology for which he was awarded 1st Class Honours and the 'Best Intercalating Student in Pharmacology Award'. He was also awarded a scholarship from the British Heart Foundation.

He undertook his general medical training 2013-2016 in North West London, which included training in Cardiology, Heart and Lung Transplantation as well as Respiratory Medicine.

Dr Hartley was awarded a Merit for completing a Post Graduate Certificate in Medical Education from Cardiff University in 2016.

He was appointed as a National Institute for Health Research Academic Clinical Fellow in Cardiology at Imperial College London and Specialist Registrar at Imperial College Healthcare NHS Trust 2017-2019, during which time he completed his general cardiology training.

Dr Hartley has completed a PhD in Cardiovascular Sciences in the NHLI, Imperial College London, which focused on the prediction, detection and treatment of atherosclerotic plaques that are at high risk of future rupture and the culprit for heart attacks. His research was supported by a prestigious Wellcome Trust PhD Fellowship. Amongst other accolades, he was awarded a Basic Science Registration Grant from the European Society of Cardiology, as well as being a finalist for the British Cardiovascular Intervention Society Young Investigator Award and Royal Society of Medicine Cardiology President’s Prize. He has been elected to Fellow of the Royal College of Physicians as well as Fellow of the European Society of Cardiology.

His clinical work encompasses general cardiology, as well as focusing on chest pain, coronary artery disease and valvular heart disease, as well as performing percutaneous coronary intervention (PCI) and transcatheter aortic valve implantation (TAVI).

He is a review editor on the editorial board of Cardiovascular Drug Delivery, specialty section of Frontiers in Drug Delivery, as well as being a topic editor for British Medical Journal Best Practice (acute heart failure, NSTEMI, STEMI, new-onset atrial fibrillation and unstable angina). He has been on the board of directors for the Imperial Vulnerable Plaque Meeting since 2021.